Statins are best known as cholesterol-lowering drugs that help prevent cardiovascular disease. However, growing evidence suggests that they may also have broader benefits, including reducing inflammation and helping the body cope with acute illness.
In our recent study, we investigated whether statin use during an acute hospital admission was associated with improved survival among older adults. We analysed data from 545 patients aged 75 years and older who were admitted to the geriatric ward at Ghent University Hospital.
We found that patients who received a statin during their hospital stay had approximately a 50% lower risk of dying during hospitalisation compared with those who did not receive a statin. This association remained after accounting for differences in age, comorbidity, physical frailty, cardiovascular disease and inflammatory status.
As this was an observational study, we cannot conclude that statins themselves caused the lower mortality. Randomised clinical trials are needed to establish whether this relationship is causal. Nevertheless, our findings add to the growing body of evidence suggesting that statins may have geroprotective effects beyond cholesterol lowering, potentially improving resilience and outcomes in older adults.
By identifying another potential benefit of these widely used medications, our study provides a foundation for future research into whether statins could play a role in improving care for vulnerable older patients.
In summary: our findings suggest that statins may offer benefits beyond lowering cholesterol during acute hospitalisation. Future randomised studies are needed to determine whether these widely used medications could become part of geroprotective strategies for older adults.
